Abstract
A possible role for Ca 2+ and calmodulin in the action of growth-hormone-releasing factor (GHRF) was investigated . Low extracellular Ca2+ (<100 μM), methoxyverapamil, flunarizine, cinnarizine, and Co2+ decreased both basal and GHRF-stimulated growth-hormone secretion, but did not totally inhibit GHRF-stimulation secretion. A calmodulin antagonist, W7, abolished GHRF-stimulated GH secretion, with no effect on basal secretion. It is suggested that GHRF may act primarily by elevating cellular cyclic AMP, which may then modulate calcium mobilization or flux; the increased intracellular Ca2+ concentrations may then activate calmodulin.
Similar content being viewed by others
References
Bicknell RJ & Schofield JG (1981) Mol. Cell. Endocrinol.22, 85–94.
Brazeau P, Ling N, Esch F, Bohlen P, Mongin C & Guillemin R (1982) Biochem. Biophys. Res. Commun.109, 588–594.
Conn PM, Rogers DC & Sheffield T (1981) Endocrinology109, 1122–1126.
Cronin MJ, Rogol AD, MacLeod RM, Keefer DA, Login IS, Borges JCL & Thorner MD (1983a) Am. J. Physiol.244, E346-E353.
Cronin MJ, Rogol AD, Myers GA & Hewlett EL (1983b) Endocrinology113, 209–215.
Dobson PRM, Baird JG, Merritt JE, Wojcikiewicz RJH & Brown BL (In preparation).
Fleischer N, Schubart UK, Fleckman A & Erlichman J (1981) In: New Perspectives on Calcium Antagonists (Weiss GB, ed), pp 177–190, American Physiological Society, Bethesda, Maryland.
Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N & Wehrenberg WB (1982) Science218, 585–587.
Hagiwara S & Byerley L (1981) Ann. Rev. Neurosci.4, 69–125.
Lemay A & Labrie F (1972) FEBS Lett.20, 7–10.
Mahaffee DD & Ontjes DA (1980) J. Biol. Chem.255, 1565–1571.
Martial JA, Seeburg PH, Guenzi D, Goodman HM & Baxter JD (1977) Proc. Natl. Acad. Sci. U.S.A.74, 4293–4295.
Merritt JE, Mac Neil S, Tomlinson S & Brown BL (1983) J. Endocrinol.98, 423–429.
Merritt JE & Brown BL (1984a) J. Endocrinol101, 319–325.
Merritt JE & Brown BL (1984b) Cell Calcium5, 159–165.
Milligan JV, Kraicer J, Fawcett CP & Illner P (1972) Can. J. Physiol. Pharmacol.50, 617–624.
Rivier J, Spiess J, Thorner MD & Vale W (1982) Nature300, 276–278.
Schrey MP, Brown BL & Ekins RP (1977) Mol. Cell. Endocrinol.8, 271–282.
Schrey MP, Brown BL & Ekins RP (1978) Mol. Cell. Endocrinol.11, 249–264.
Sheppard MS, Kraicer J & Milligan JV (1980) In: Synthesis and Release of Adenohypophysial Hormones (Justisz M & McKerns KW, eds), pp 495–523, Plenum Press, New York.
Spence JW, Sheppard S & Kraicer J (1980) Endocrinology106, 764–769.
Spiess J, Rivier J & Wale W (1983) Nature303, 502–535.
Steiner SL, Peake GT, Utiger RD, Karl ET & Kipnis DM (1970) Endocrinology86, 1354–1360.
Vale W, Vaughan J, Yamamoto G, Spiess J & Rivier J (1983) Endocrinology112, 1553–1555.
Wehrenberg WB, Ling N, Bohlen P, Esch F, Brazeau P & Guillemin R (1982) Biochem. Biophys. Res. Commun.109, 562–567.
Wilson MC, Steiner AL, Dhariwal AP & Peake GT (1974) Neuroendocrinology15, 313–327.
Yancey SB, Weiner R & Schechter J (1980) Am. J. Anat.157, 345–356.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merritt, J.E., Dobson, P.R.M., Wojcikiewicz, R.J.H. et al. Studies on the involvement of calcium and calmodulin in the action of growth-hormone-releasing factor. Biosci Rep 4, 995–1000 (1984). https://doi.org/10.1007/BF01116691
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01116691